Immunovative, Inc.
Immunovative, Inc. (IMUN) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 886 transactions totaling $733.1K, demonstrating a bullish sentiment with $733.1K in net insider flow. The most recent transaction on Feb 10, 2023 involved a purchase of 409,000 shares valued at $20.4K.
IMUN Insider Activity Summary
Who Is Buying IMUN Stock?
No significant insider buying has been recorded for IMUN in the recent period.
Who Is Selling IMUN Stock?
No significant insider selling has been recorded for IMUN in the recent period.
Is Immunovative, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IMUN is bullish with an Insider Alignment Score of 100/100 and a net flow of $733.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IMUN Frequently Asked Questions
Understanding IMUN Insider Activity
Insider trading at Immunovative, Inc. (IMUN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading IMUN stock, having executed 886 transactions in the past 90 days. The most active insider is Robert Jackman Dailey (Executive), who has made 462 transactions totaling $832.3K.
Related Tools
Track Immunovative, Inc. Insider Activity
Get notified when executives and directors at IMUN file new Form 4 transactions